Literature DB >> 11883070

Generation and growth of gutted adenoviral vectors.

Dennis Hartigan-O'Connor1, Catherine Barjot, Giovanni Salvatori, Jeffrey S Chamberlain.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 11883070     DOI： 10.1016/s0076-6879(02)46058-2

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  9 in total

Review 1.  Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders.

Authors:  Pedro R Lowenstein; Donata Suwelack; Jinwei Hu; Xianpeng Yuan; Maximiliano Jimenez-Dalmaroni; Shyam Goverdhana; Maria G Castro
Journal:  Int Rev Neurobiol       Date:  2003       Impact factor: 3.230

Review 2.  Human gene therapy and imaging in neurological diseases.

Authors:  Andreas H Jacobs; Alexandra Winkler; Maria G Castro; Pedro Lowenstein
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-12       Impact factor: 9.236

3.  Tightly regulated gene expression in human hematopoietic stem cells after transduction with helper-dependent Ad5/35 vectors.

Authors:  Hongje Wang; Hua Cao; Martin Wohlfahrt; Hans-Peter Kiem; André Lieber
Journal:  Exp Hematol       Date:  2008-04-18       Impact factor: 3.084

4.  Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin.

Authors:  Dejia Li; Akshay Bareja; Luke Judge; Yongping Yue; Yi Lai; Rebecca Fairclough; Kay E Davies; Jeffrey S Chamberlain; Dongsheng Duan
Journal:  J Cell Sci       Date:  2010-05-18       Impact factor: 5.285

5.  A helper-dependent capsid-modified adenovirus vector expressing adeno-associated virus rep78 mediates site-specific integration of a 27-kilobase transgene cassette.

Authors:  Hongjie Wang; André Lieber
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

6.  A preliminary and comparative evaluation of a novel Ad5 [E1-, E2b-] recombinant-based vaccine used to induce cell mediated immune responses.

Authors:  Elizabeth S Gabitzsch; Younong Xu; Lois H Yoshida; Joseph Balint; Richard B Gayle; Andrea Amalfitano; Frank R Jones
Journal:  Immunol Lett       Date:  2008-12-13       Impact factor: 3.685

Review 7.  Gene therapy in large animal models of muscular dystrophy.

Authors:  Zejing Wang; Jeffrey S Chamberlain; Stephen J Tapscott; Rainer Storb
Journal:  ILAR J       Date:  2009

8.  Functional correction of adult mdx mouse muscle using gutted adenoviral vectors expressing full-length dystrophin.

Authors:  Christiana DelloRusso; Jeannine M Scott; Dennis Hartigan-O'Connor; Giovanni Salvatori; Catherine Barjot; Ann S Robinson; Robert W Crawford; Susan V Brooks; Jeffrey S Chamberlain
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-23       Impact factor: 11.205

Review 9.  Emerging strategies for cell and gene therapy of the muscular dystrophies.

Authors:  Lindsey A Muir; Jeffrey S Chamberlain
Journal:  Expert Rev Mol Med       Date:  2009-06-25       Impact factor: 5.600
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.